Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Differential effect of anticoagulation according to cognitive function and frailty in older patients with atrial fibrillation.
FAK tyrosine phosphorylation is regulated by AMPK and controls metabolism in human skeletal muscle.
Developing Smokers for Smoker (S4S): A Collective Intelligence tailoring system
Bioorthogonal nanozymes for breast cancer imaging and therapy.
Pitfalls in developing new compounds for idiopathic pulmonary fibrosis.
See All 20 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pitfalls in developing new compounds for idiopathic pulmonary fibrosis.
Nathan SD, Martinez FJ. Pitfalls in developing new compounds for idiopathic pulmonary fibrosis. Curr Opin Pulm Med. 2017 09; 23(5):426-431.
View in:
PubMed
subject areas
Clinical Trials as Topic
Drug Discovery
Humans
Idiopathic Pulmonary Fibrosis
Patient Selection
Precision Medicine
Research Design
authors with profiles
Fernando J Martinez MD, MS